Abstract submission rules

CoMeT Congress 2016

Abstracts can be submitted via the online Abstract Submission Services only.

Abstracts sent by fax or email will not be accepted.

The submission deadline has been extended to Sunday 25th September 2016, 23:59 CET (Central European Time). No late submission will be accepted.

 

GENERAL INFORMATION
Changes and corrections: Once submitted, it is not possible to make any corrections to the abstract content or information (such as authors list and details, topic, conclusion(s) etc…). The Scientific Board is not authorized to make changes to a submission. In order to correct your abstract you must withdraw it and submit a new corrected version prior to the deadline (See below for withdrawal procedure). Note that, such replacement of your abstract is not possible after the deadline. In the case of errors in your abstract discovered after the deadline, you may indicate the correction during the presentation at the congress. However, changes will not be included in the publications. If accepted, your abstract will be published as submitted.

Withdrawal: If you want to withdraw an abstract already submitted, please notify us as quickly as possible at abstract@comet2016.org stating the title and the authors of the abstract to be withdrawn.
Note that, withdrawals are still accepted after the submission deadline but abstracts may still appear in publications. All abstract withdrawal requests must be received in writing (via e-mail) by August 2016.

 Step 1: Abstract Information

Title: Maximum 200 characters typed in lower-case letters, except for abbreviations and study names. Please be careful that your title might be truncated if you copy and paste it into the field. Do not include authors, institutions, city names, trademarks and abbreviations in the title.

Category: You must select one of the following categories, under which your abstract can be best classified:
• PREVENTION IN OCCUPATIONAL MEDICINE: protocols derived from national laws, devices useful in prevention on stage, technical hints to ameliorate prevention…
• PREVENTION IN ARTISTS’ LIFE: Education to prevention. Prevention of early damage to an artistic career. Long lasting prevention in aging Artists…

On behalf of: You may use this field to enter the name of the affiliation for your research or the name of an investigating team. Do not use this field to list individual authors.
Affiliation/Investigating team will not be listed in the authors index of the Scientific Programme but will appear in publications.

Funding Acknowledgements: All sources of financial support (including governmental grants) for this research should be listed under this heading. All grant funding agency abbreviations should be spelled out. This information will be published.

Acronyms: If the study to be presented is known through an acronym, please indicate the name of the study (e.g. “AB’sH”) in the appropriate field, as well as the full name of the acronym (e.g. “Artist Body‘s Health”).

Step 2: Abstract authors and institutions
Your abstract must list at least 1 author in order to be submitted.

Authors list: Please note that the first author should be the abstract Presenter by default

In all cases, the Presenter must be part of the authors list included in the submitted abstract and be able to explain his/her role in the research during presentation. You may enter up to 5 authors in the authors list, including the Presenter. The names of authors will be published as listed on the submission form. Please make sure you have enter the full list of authors and that the information given for each author is correct, as no changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).
The authors’ order and institution will be published as entered by the submitter.
The submitter certifies that he/she has permission from all persons he/she enters as co-authors to be listed in this abstract and that they are aware that their names will appear in all publications.
If none of the authors are able to present the abstract during the congress, the abstract should be withdrawn

Institutions
You will be requested to select your institution when you create the presenter and the authors. If you are presenting on your own, type “None”.

 Step 3: Abstract Content
All abstracts must be submitted (and will be presented) in English using UK English spelling with accurate grammar and spelling suitable for publication. If in doubt, please arrange for the review of your abstract by a native English speaker, by a university scientific publications office (or other similar facility) prior to submission.

We recommend you structure your abstract using the following headings:
Background/Introduction
Purpose
Methods
Results
Conclusion(s)
There is not a specific maximum of words, but rather a maximum total size of the abstracts (shown as 100 %), including the text with spaces, table (if any). The maximum abstract size is 35 lines (3 000 characters).

Abstract table: you can add a picture of your table, using the same criteria of the picture.

Abstract picture: Your picture file must meet the following criteria:
Format: JPEG, PNG or PDF
Size: less than 1 MB
Measures no larger than 600 pixels(x) x 800 pixels(y)

Please make sure that your picture is readable on the abstract preview (this represents how it will look in all publications). You can only enter one picture, and the title field is optional.

not authorised
•    Trademarks. Use generic drug names. The use of commercial drug names, brands and registered trademarks is strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation
•    Company names and location
•    Web sites and email addresses (if commercial)

Failure to comply with the above requirements will/may lead to automatic rejection of the submission

Do not include grant acknowledgements in the abstract content. Use the appropriate field.

Do not cite keywords or references in the abstract, as they are not allowed and will be deleted.

Do not include copyright or trademark symbols.

Limit use of acronyms and abbreviations. Define at first use with acronym or abbreviation in parentheses.

We remind you that patient’s photo should be avoided and the patient must never be identifiable in your presentation.

Step 4: Abstract Preview and submission
Proofread abstracts carefully to avoid errors before submission, check spelling and grammar. The abstract will be reviewed and published (if accepted) as it has been submitted – NO EXCEPTIONS.

Do not forget to click on the Submit button to validate your abstract submission. After having submitted your abstract, you will receive an immediate automatic confirmation by email (please make sure to state your correct email address!) notifying you the abstract number. Please use this reference in all correspondence. If you do not receive this confirmation, please contact the Scientific Committee

There is no limit to the number of abstracts an author/individual may submit, but the same research cannot be submitted twice, even under a different topic/category or with a different title. If you submit two abstracts with the same content, the abstract submission service will automatically keep the most recent abstract submitted and withdraw the other. Note that duplicate draft abstracts will not be deleted.

If you have difficulties in submitting your abstracts or if you need any further information, please contact the Scientific Committee
Abstracts submitted for consideration must be an original idea, concept, or an improvement or revision of a previous idea. Submissions are peer-reviewed for scientific content, logical presentation, and current interest of the topic to the scientific community.

Accepted abstracts will be scheduled either as oral presentations or Act of the COMET2016.

All presentations, including question-and-answers, will be conducted in English. Presenters are expected to speak a good English.

All abstract submitters will be notified by e-mail by September 2016 about the outcome (accepted or not accepted) of the review and selection process.  Please ensure that the email provided is accurate as all correspondences will be sent via email.

If the abstract is accepted, instructions and guidelines concerning the abstract presentation will be provided online.
The same presenter cannot be assigned to more than 3 abstracts – co-authors should then be assigned as presenters.

All expenses (airfare, hotel….) associated with the submission and presentation of an abstract, are under the responsibility of the presenter.

No-show Policy
Submission of an abstract constitutes a formal commitment by the author(s) to present the work if accepted. Failure to present and register for the Congress, if not justified (withdrawn), will be identified as “no-show”. In addition, abstracts identified as “no-show” will be removed from all Congress publications.

Publication of abstracts
All accepted abstracts will be published in the COMET 2016 acts (online version)

Affirmation of Originality and Copyrights transfer statement
•    By submitting your work to the COMET 2016, you consent to have authors’ names, affiliation and biographical material used in connection with the publication of your work.
•    Author(s) represents and warrants that he/she/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.
The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders, and that all statements declared as facts are based on thorough examination and investigation for accurateness.
The content belongs to the author(s). However, if the abstract is accepted the submitter agrees, on behalf of all co-authors, to transfer and assign to the COMET the rights to edit, publish, reproduce, distribute copies and prepare derivative works such as press releases. This includes use in indexes or search databases in print, electronic, or other media.
Author(s) retain the right, after presentation at the Congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits, provided said use does not imply the endorsement of the COMET.
The submitter signs for all co-authors. He/she accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.
Conflict of interest
The Congress Programme Committee requests all presenters to display a slide at the beginning of their presentation (at the bottom of the poster for poster presentations) indicating disclosure information for themselves and all coauthors as applicable, or that they have nothing to disclose. Please state “None” if no conflicts exist.
This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.
All potential conflicts of interest must be stated.
This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, being on the board of directors, or being publicly associated with the company or its products. Other areas of real or perceived conflict of interest could include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations.

Data Privacy
By certifying that you have read these Submission rules, you also confirm having received the prior approval from the co-authors to provide their data to the COMET. Your personal data will be managed according by the Italian Law, by Beacon Srl.